Introduction
Diagnostic testing has been quietly moving out of the central lab for years, and that shift has picked up real momentum: rapid tests in retail clinics and pharmacies, molecular panels run at the bedside in emergency departments, and self-collection kits that patients use at home and either read themselves or mail to a lab. Each of these settings brings a product into contact with a person who is not a trained laboratory technologist, under conditions the manufacturer does not control, and that changes what a regulatory affairs professional working on these products actually needs to know. Point-of-care and at-home diagnostics have grown into a genuine hiring niche within medical device and IVD regulatory affairs, distinct enough from traditional laboratory-based IVD work that companies increasingly look for candidates with specific experience in it rather than assuming general diagnostics regulatory experience transfers directly.
What Makes This Niche Different From Traditional IVD Regulatory Work
A test run by a trained technologist on calibrated laboratory equipment, following a written procedure, in a controlled environment, is a fundamentally different regulatory problem than a test a consumer performs on their kitchen counter after reading an instruction card once. Traditional laboratory-based in vitro diagnostics regulatory work centers heavily on analytical and clinical performance data generated under controlled conditions. Point-of-care and at-home diagnostics regulatory work still requires all of that, but layers on an entirely additional set of concerns: whether an untrained user can actually follow the instructions correctly, whether the test performs reliably outside a controlled lab environment, whether the result is interpreted correctly without a trained reader, and whether the complexity of the test qualifies it for a CLIA waiver that allows it to be used in a wider range of settings in the first place. A regulatory professional in this space needs working fluency in usability and human factors evaluation in a way that a purely laboratory-focused IVD regulatory career often does not require to the same degree.
CLIA Waiver Status as a Central Regulatory and Commercial Question
In the United States, whether a diagnostic test can be performed in a point-of-care or at-home setting is governed substantially by its status under the Clinical Laboratory Improvement Amendments framework. A test classified as CLIA-waived can be performed in a much broader range of settings, including physician office labs, retail clinics, and in some cases directly by a consumer, without the operator holding a laboratory certification for moderate or high complexity testing. Securing waived status is not a formality; it typically requires demonstrating, through structured studies, that the test can be performed accurately by untrained or minimally trained users following the labeling as written, with an acceptably low risk of user error leading to an incorrect result. For a company building a point-of-care or at-home diagnostic, CLIA waiver status is often as commercially important as the underlying clearance or approval itself, because it directly determines how widely the product can actually be sold and used. Regulatory professionals who understand how to plan and execute a waiver study, and how to build labeling and packaging that supports a waiver argument from the earliest stages of development, are genuinely valuable in this niche.
Human Factors and Usability Take on Outsized Importance
Human factors and usability engineering matter in every medical device and diagnostic program, but in point-of-care and at-home diagnostics they move from an important supporting workstream to something close to central. A test intended for lay use has to be evaluated with representative users, often including people with a range of literacy levels, ages, and physical abilities, performing the actual test under conditions that mimic real-world use as closely as possible. Regulatory professionals in this niche work closely with human factors specialists to design these studies, to interpret use errors that occur during testing and determine whether they indicate a labeling problem, a design problem, or an acceptable and expected variation, and to build the regulatory narrative around why the final design and labeling adequately mitigate use-related risk. This is genuinely different work from writing a traditional analytical performance summary, and candidates who have hands-on experience running or supporting human factors studies for a diagnostic or device intended for lay use stand out in this hiring pool.
Connectivity, Software, and Result Reporting
A growing share of point-of-care and at-home diagnostics connect to a smartphone app or a cloud-based platform, whether to help a lay user interpret a visual result more consistently, to transmit a result automatically to a healthcare provider or public health authority, or to support a telehealth workflow around the test. This introduces a software regulatory dimension on top of the core diagnostic regulatory pathway, including questions about whether the connected software itself qualifies as part of the regulated device, how result data is handled and reported, and how cybersecurity and data privacy requirements apply to a consumer-facing health app. Regulatory professionals who can speak comfortably across both the traditional IVD regulatory framework and the software and digital health regulatory landscape are unusually well positioned in this niche, since few candidates come in fluent in both from day one.
Where These Roles Sit and What Employers Are Looking For
Companies hiring for this niche range from established diagnostics manufacturers building out a point-of-care or consumer product line alongside their traditional laboratory business, to newer diagnostics companies built specifically around decentralized or home testing, to digital health companies partnering with a diagnostics manufacturer to build the connected experience around a test. Job postings in this space increasingly name CLIA waiver experience, human factors and usability study experience, and comfort with FDA's evolving guidance on home use and over-the-counter diagnostics as specific, named qualifications, rather than folding them into a generic IVD regulatory affairs job description. Candidates coming from a traditional laboratory-based IVD regulatory background can absolutely move into this niche, but they should expect to actively build and be able to speak to experience in usability evaluation and waiver strategy specifically, since employers are increasingly screening for it directly rather than assuming it will be picked up on the job.
Multiplexed Tests and Public Health Reporting Add Another Layer
A related trend worth understanding is the growth of multiplexed point-of-care and at-home tests, panels that check for several conditions from a single sample, such as a combined respiratory panel distinguishing between a handful of common viral causes of similar symptoms. Multiplexed tests raise their own regulatory questions beyond single-analyte usability and waiver concerns: how results for multiple targets are presented to a lay user without causing confusion, how a negative result for one target but a positive for another is communicated clearly, and how performance claims are supported across every analyte in the panel rather than just the primary one. Some of these tests also feed directly into public health surveillance infrastructure, particularly for reportable infectious diseases, which means a regulatory professional working in this space increasingly needs at least a working understanding of how results flow to public health authorities and what data reporting obligations attach to a point-of-care or at-home result once it exists. This is a genuinely newer piece of the regulatory landscape, and professionals who follow how agencies are handling it, rather than assuming it works the same way established single-analyte tests do, tend to be ahead of most of the hiring pool.
How to Position Yourself for This Niche
For a regulatory affairs professional interested in this space, the most useful moves are concrete ones. Volunteer for or seek out involvement in any human factors or usability study on a current program, even a peripheral role, since direct exposure to how these studies are designed and interpreted is difficult to fake in an interview. Read FDA's published guidance on CLIA waiver applications and on home use devices closely enough to discuss the practical implications, not just the existence, of the requirements. Pay attention to how connected or software-enabled features are being regulated on any program you touch, even if software is not your primary responsibility, because that cross-functional fluency is exactly what differentiates a candidate in this niche from a generalist IVD regulatory professional. None of this requires switching employers immediately; it can be built within a current role by deliberately seeking out the parts of a program that touch these areas.
Training and Labeling Are Regulatory Deliverables, Not Marketing Afterthoughts
In a traditional lab-based IVD program, instructions for use are written primarily for a trained laboratory audience and reviewed accordingly. In a point-of-care or at-home program, the instructions for use, quick reference card, and any packaging insert are themselves core regulatory deliverables that get tested directly against real users during human factors studies, revised based on where those users struggled, and retested until the data supports that the labeling adequately guides correct use. Regulatory professionals in this niche routinely sit alongside human factors specialists, technical writers, and sometimes marketing or packaging teams to negotiate the tension between a label that is legally and scientifically complete and one that a nervous, untrained user can actually follow correctly under real conditions, often while managing symptoms or anxiety about the result. Getting comfortable with this kind of cross-functional labeling work, including knowing when a marketing team's preferred wording creates a genuine usability risk worth pushing back on, is a practical skill that develops with direct exposure and is difficult to convey in an interview without having actually done it.
Conclusion
Diagnostic testing is moving closer to the patient, whether that means a retail pharmacy, an emergency department bedside, or a kitchen counter, and the regulatory work required to support that shift is measurably different from traditional laboratory-based IVD regulatory affairs. CLIA waiver strategy, human factors and usability evaluation, and connected software regulatory fluency are becoming the defining skills of this niche, and regulatory professionals who build genuine depth in them, rather than treating them as adjacent concerns, are well positioned for a growing and increasingly well-defined segment of the diagnostics hiring market.